Advertisement

Structure-Function Relationships for High and Low-Affinity Interleukin 2 Receptors

  • Richard J. Robb

Abstract

The original study of interleukin 2 (IL-2) binding to activated lymphocytes by Robb and colleagues1 described a high-affinity receptor-ligand association which fit nicely with the very low levels of IL-2 which promoted cellular proliferation. Later studies, however, demonstrated that the IL-2 receptor actually existed in a number of forms with drastically different affinities for ligand2. Our subsequent research has focused on explaining these differences in molecular terms and relating them to the function of this versatile growth and differentiation factor. Insight into structure-function relationships for the IL-2-receptor system should prove particularly valuable to the design of drugs which can be used to manipulate IL-2-dependent immunological responses.

Keywords

Versatile Growth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. J. Robb, A. Munck, and K. A. Smith, T cell growth factor receptors: quantitation, specificity, and biological relevance, J. Exp. Med. 154: 1455 (1981).PubMedCrossRefGoogle Scholar
  2. 2.
    R. J. Robb, W. C. Greene, and C. M. Rusk, Low and high affinity cellular receptors for interleukin 2: implications for the level of Tac antigen, J. Exp. Med. 16Ó: 1126 (1984).Google Scholar
  3. 3.
    R. J. Robb, C. M. Rusk, J. Yodoi, and W. C. Greene, An interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors, Proc. Natl. Acad. Sci. USA 84: 2002 (1987).Google Scholar
  4. 4.
    M. Sharon, R. D. Klausner, B. R. Cullen, R. Chizzonite, and W. J. Leonard, Novel interleukin 2 receptor subunit detected by crosslinking under high-affinity conditions, Science 234: 859 (1980).CrossRefGoogle Scholar
  5. 5.
    M. Tsudo, R. W. Kozak, C. K. Goldman, and T. A. Waldmann, Demonstration of a new non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin-2 receptor complex, Proc. Natl. Acad. Sci USA 83: 9694 (1986).PubMedCrossRefGoogle Scholar
  6. 6.
    K. Teshigawara, H.-M. Wang, K. Kato, and K. A. Smith, Interleukin 2 high-affinity receptor expression requires two distinct binding proteins, J. Exp. Med. 165: 223 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    W. J. Leonard, J. M. Depper, T. Uchiyama, K. A. Smith, T. A. Waldmann, and W. C. Greene, A monoclonal antibody that appears to recognize the receptor for human T cell growth factor, Nature 300: 267 (1982).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Hatakeyama, S. Minamoto, T. Uchiyama, R. R. Hardy, G. Yamada, and T. Taniguchi, Reconstitution of functional receptor for human interleukin-2 in mouse cells, Nature 318: 467 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Kondo, A. Shimizu, M. Maeda, Y. Tagaya, J. Yodoi, and T. Honjo, Expression of functional human interleukin 2 receptor in mouse T cells by cDNA transfection, Nature 320: 75 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    S. Kondo, A. Shimizu, Y. Saito, M. Kinoshita, and T. Honjo, Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model, Proc. Natl. Acad. Sci. USA 83: 9026 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    R. J. Robb, Conversion of low-affinity interleukin 2 receptors to a high-affinity state following fusion of cell membranes, Proc. Natl. Acad. Sci. USA 83: 3992 (1986).PubMedCrossRefGoogle Scholar
  12. 12.
    M. Fujii, K. Sugamura, K. Sano, M. Nakai, K. Sugita, and Y. Hinuma, High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells, J. Exp. Med. 163: 550 (1986).PubMedCrossRefGoogle Scholar
  13. 13.
    L.-M. Kuo, C. M. Rusk, and R. J. Robb, Structure-function relationships for the IL 2-receptor system II. Localization of an IL 2 binding site in high and low-affinity receptors, J. Immunol. 137: 1544 (1986).PubMedGoogle Scholar
  14. 14.
    M. P. Neeper, L.-M Kuo, M. C. Kiefer, and R. J. Robb, Structure-function relationships for the IL 2-receptor system. III. Tac protein missing amino acids 102–173 (exon 4) is unable to bind IL 2. Detection of spliced protein after L cell transfection, J. Immunol. 138: 3532 (1987).PubMedGoogle Scholar
  15. 15.
    C. M. Rusk, M. P. Neeper, L.-M. Kuo, R. M. Kutny and R. J. Robb, Structure-function relationships for the IL-2 receptor system. V. Structure-activity analysis of modified and truncated forms of the Tac receptor protein. Site-specific mutagenesis of cysteine residues, J. Immunol. in press.Google Scholar
  16. 16.
    J. R. Ortaldo, A. T. Mason, J. P. Gerard, L. E. Henderson, W. Farrar, R. F. Hopkins, R. B. Herberman, and H. Rabin, Effects of natural and recombinant IL-2 on regulation of IFN 3d production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects, J. Immunol. 133: 779 (1984).PubMedGoogle Scholar
  17. 17.
    P. Ralph, G. Jeong, K., Welte, R. Mertelsmann, H. Rabin, L. E. Henderson, L. M. Souza, T. C. Boone, and R. J. Robb, Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentration of IL-2, J. Immunol. 133: 2442 (1984).PubMedGoogle Scholar
  18. 18.
    M. Dukovich, Y. Wano, Le Thi Bich Thuy, P. Katz, B. R. Callen, J. H. Kerhl and W. C. Greene, A second human interleukin 2 binding protein that may be a component of high-affinity interleukin-2 receptors, Nature 327: 518 (1987).PubMedCrossRefGoogle Scholar
  19. 19.
    R. J. Robb, and W. C. Greene, Internalization of interleukin 2 is mediated by the beta chain of the high-affinity IL-2 receptor, J. Exp. Med. 165: 1201 (1987).PubMedCrossRefGoogle Scholar
  20. 20.
    R. J. Robb, Structure-function relationships for the interleukin 2 receptor. In: Molecular and Cellular Aspects of Inflammation G. Poste and S.T. Cooke, eds., Plenum Press, NY, pp. 97–122 (1988).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Richard J. Robb
    • 1
  1. 1.Medical Products DepartmentE. I. du Pont de Nemours & Co.GlenoldenUSA

Personalised recommendations